within Pharmacolibrary.Drugs.C_CardiovascularSystem.C08C_SelectiveCalciumChannelBlockersWithMainlyVascularEffects.C08CA01_Amlodipine;

model Amlodipine
  extends Pharmacolibrary.Drugs.ATC.C.C08CA01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C08CA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Amlodipine is a long-acting dihydropyridine calcium channel blocker used primarily for the treatment of hypertension and angina pectoris. It is orally administered and is widely approved and used as first-line therapy for blood pressure control.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral 5 mg dose.</p><h4>References</h4><ol><li><p>Meredith, PA, &amp; Elliott, HL (1992). Clinical pharmacokinetics of amlodipine. <i>Clinical pharmacokinetics</i> 22(1) 22–31. DOI:<a href=\"https://doi.org/10.2165/00003088-199222010-00003\">10.2165/00003088-199222010-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1532771/\">https://pubmed.ncbi.nlm.nih.gov/1532771</a></p></li><li><p>Abernethy, DR (1992). Pharmacokinetics and pharmacodynamics of amlodipine. <i>Cardiology</i> 80 Suppl 1 31–36. DOI:<a href=\"https://doi.org/10.1159/000175050\">10.1159/000175050</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1534713/\">https://pubmed.ncbi.nlm.nih.gov/1534713</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Amlodipine;
